-
1
-
-
0242684416
-
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
-
PMid:12724479
-
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-1746. PMid:12724479. http://dx.doi.org/10.1056/NEJMoa022823
-
(2003)
N Engl J Med
, vol.348
, Issue.18
, pp. 1737-1746
-
-
Whitney, C.G.1
Farley, M.M.2
Hadler, J.3
Harrison, L.H.4
Bennett, N.M.5
Lynfield, R.6
-
2
-
-
67651097472
-
Invasive pneumococcal disease among adults: Associations among serotypes, disease characteristics, and outcome
-
PMid:19522653
-
Jansen AG, Rodenburg GD, van der Ende A, van Alphen L, Veenhoven RH, Spanjaard L, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis. 2009;49(2):e23. PMid:19522653. http://dx.doi.org/10.1086/600045
-
(2009)
Clin Infect Dis
, vol.49
, Issue.2
-
-
Jansen, A.G.1
Rodenburg, G.D.2
van der Ende, A.3
van Alphen, L.4
Veenhoven, R.H.5
Spanjaard, L.6
-
3
-
-
82655184141
-
Initial management of and outcome in patients with pneumococcal bacteremia: A retrospective study at a Swiss university hospital, 2003-2009
-
PMid:22065426
-
Giner AM, Kuster SP, Zbinden R, Ruef C, Ledergerber B, Weber R. Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009. Infection. 2011;39(6):519-526. PMid:22065426. http://dx.doi.org/10.1007/s15010-011-0218-1
-
(2011)
Infection
, vol.39
, Issue.6
, pp. 519-526
-
-
Giner, A.M.1
Kuster, S.P.2
Zbinden, R.3
Ruef, C.4
Ledergerber, B.5
Weber, R.6
-
4
-
-
0033858034
-
Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study
-
PMid:10941350
-
Musher DM, Alexandraki I, Graviss EA, Yanbeiy N, Eid A, Inderias LA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore). 2000;79(4):210-221. PMid:10941350. http://dx.doi.org/10.1097/00005792-200007000-00002
-
(2000)
Medicine (Baltimore)
, vol.79
, Issue.4
, pp. 210-221
-
-
Musher, D.M.1
Alexandraki, I.2
Graviss, E.A.3
Yanbeiy, N.4
Eid, A.5
Inderias, L.A.6
-
5
-
-
0031552194
-
Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1-24.
-
(1997)
MMWR Recomm Rep
, vol.46
, Issue.RR-8
, pp. 1-24
-
-
-
6
-
-
77951092006
-
Streptococcus pneumoniae: Epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines
-
PMid:20375783
-
Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16(3):217-225. PMid:20375783.
-
(2010)
Curr Opin Pulm Med
, vol.16
, Issue.3
, pp. 217-225
-
-
Lynch, J.P.1
Zhanel, G.G.2
-
7
-
-
79551526450
-
Bacteraemic pneumococcal pneumonia: Current therapeutic options
-
PMid:21275443
-
Feldman C, Anderson R. Bacteraemic pneumococcal pneumonia: current therapeutic options. Drugs. 2011;71(2):131-153. PMid:21275443. http://dx.doi.org/10.2165/11585310-000000000-00000
-
(2011)
Drugs
, vol.71
, Issue.2
, pp. 131-153
-
-
Feldman, C.1
Anderson, R.2
-
8
-
-
0001372661
-
Pneumococcal Bacteremia with especial reference to bacteremic pneumococcal pneumonia
-
PMid:14156606
-
Austrian R, Gold J. Pneumococcal Bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759-776. PMid:14156606.
-
(1964)
Ann Intern Med
, vol.60
, pp. 759-776
-
-
Austrian, R.1
Gold, J.2
-
9
-
-
10744232969
-
A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology-- results from a Canadian multicentre study
-
Canadian Community- Acquired Pneumonia Investigators, PMid:14571288. PMid:14571288
-
Marrie TJ, Low DE, De Carolis E; Canadian Community- Acquired Pneumonia Investigators. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology-- results from a Canadian multicentre study. Can Respir J. 2003;10(7):368-374. PMid:14571288. PMid:14571288.
-
(2003)
Can Respir J
, vol.10
, Issue.7
, pp. 368-374
-
-
Marrie, T.J.1
Low, D.E.2
de Carolis, E.3
-
10
-
-
40549108652
-
The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study
-
PMid:18198264
-
Bordón J, Peyrani P, Brock GN, Blasi F, Rello J, File T, et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest. 2008;133(3):618-624. PMid:18198264. http://dx.doi.org/10.1378/chest.07-1322
-
(2008)
Chest
, vol.133
, Issue.3
, pp. 618-624
-
-
Bordón, J.1
Peyrani, P.2
Brock, G.N.3
Blasi, F.4
Rello, J.5
File, T.6
-
11
-
-
84866395890
-
Impact of bacteremia in a cohort of patients with pneumococcal pneumonia
-
Palma I, Mosquera R, Demier C, Vay C, Famiglietti A, Luna C. Impact of bacteremia in a cohort of patients with pneumococcal pneumonia. J Bras Pneumol. 2012; 38(4):422-430.
-
(2012)
J Bras Pneumol
, vol.38
, Issue.4
, pp. 422-430
-
-
Palma, I.1
Mosquera, R.2
Demier, C.3
Vay, C.4
Famiglietti, A.5
Luna, C.6
-
12
-
-
76649108241
-
Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: Importance of early adequate treatment
-
PMid:20085422
-
Garnacho-Montero J, García-Cabrera E, Diaz-Martín A, Lepe-Jiménez JA, Iraurgi-Arcarazo P, Jiménez-Alvarez R, et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand. J Infect Dis. 2010; 42(3):185-192. PMid:20085422. http://dx.doi.org/10.3109/00365540903418522
-
(2010)
Scand. J Infect Dis
, vol.42
, Issue.3
, pp. 185-192
-
-
Garnacho-Montero, J.1
García-Cabrera, E.2
Diaz-Martín, A.3
Lepe-Jiménez, J.A.4
Iraurgi-Arcarazo, P.5
Jiménez-Alvarez, R.6
-
13
-
-
1542719625
-
Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality
-
PMid:15090938
-
Lujan M, Gallego M, Fontanals D, Mariscal D, Rello J. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality. Crit Care Med. 2004; 32(3):625-631. PMid:15090938. http://dx.doi.org/10.1097/01.CCM.0000114817.58194.BF
-
(2004)
Crit Care Med
, vol.32
, Issue.3
, pp. 625-631
-
-
Lujan, M.1
Gallego, M.2
Fontanals, D.3
Mariscal, D.4
Rello, J.5
-
14
-
-
0037442372
-
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
-
PMid:12567294
-
Martinez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2003; 36(4):389-395. PMid:12567294. http://dx.doi.org/10.1086/367541
-
(2003)
Clin Infect Dis
, vol.36
, Issue.4
, pp. 389-395
-
-
Martinez, J.A.1
Horcajada, J.P.2
Almela, M.3
Marco, F.4
Soriano, A.5
García, E.6
-
15
-
-
73449104256
-
Pneumococcal pneumonia presenting with septic shock: Host- and pathogen-related factors and outcomes
-
PMid:19996337
-
Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Liñares J, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax. 2010;65(1):77-81. PMid:19996337. http://dx.doi.org/10.1136/thx.2009.123612
-
(2010)
Thorax
, vol.65
, Issue.1
, pp. 77-81
-
-
Garcia-Vidal, C.1
Ardanuy, C.2
Tubau, F.3
Viasus, D.4
Dorca, J.5
Liñares, J.6
|